Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of two halophenol compounds in preparation of medicines of resisting type II diabetic nephropathy

A technology for diabetic nephropathy and a compound is applied in the application field of preparing anti-type II diabetic nephropathy drugs, which can solve the problem of no relevant reports on the pharmacological effects of anti-type II diabetic nephropathy, and achieve the effects of strong renal protection and improvement of renal function.

Active Publication Date: 2016-08-03
SHANXI MEDICAL UNIV
View PDF4 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] But so far, for compound 4,5,2'-trihydroxy-2,5'-dibromobenzophenone and compound 4,5,2'-tris(4-morpholinoyloxy)-2 , There is no relevant report at home and abroad on the pharmacological effects of 5'-dichlorobenzophenone against type Ⅱ diabetic nephropathy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of two halophenol compounds in preparation of medicines of resisting type II diabetic nephropathy
  • Application of two halophenol compounds in preparation of medicines of resisting type II diabetic nephropathy
  • Application of two halophenol compounds in preparation of medicines of resisting type II diabetic nephropathy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0018] Compound 4,5,2'-trihydroxy-2,5'-dibromobenzophenone and compound 4,5,2'-tris(4-morpholinoyloxy)-2,5'-dichloro Application of benzophenone in the preparation of anti-Ⅱ diabetic nephropathy drugs.

[0019] A drug against type II diabetic nephropathy, the active ingredient of which is compound 4,5,2'-trihydroxy-2,5'-dibromobenzophenone, or compound 4,5,2'-tri(4 -morpholinoyloxy)-2,5'-dichlorobenzophenone. The drug also includes common pharmaceutical carriers or excipients used in combination with the active ingredients. The medicine can be made into common dosage forms such as injections, tablets, dropping pills, solid dispersions or capsules according to specific requirements.

[0020] The following specific experimental examples will further illustrate the anti-type II diabetic nephropathy function of the two halophenol compounds in the present invention. It should be noted that the following examples are all illustrative and do not make any contribution to the present...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medical new application of two halophenol compounds 4,5,2'-trihydroxy-2,5'-dibromobenzophenone and 4,5,2'-tri(4-morpholine methanoyl)-2,5'-dibromobenzophenone, in particular an application in preparation of medicines of resisting type II diabetic nephropathy. Meanwhile, the invention also discloses a medicine of resisting type II diabetic nephropathy employing the two halophenol compounds as active ingredients. By the two compounds, the renal function of the type II diabetic nephropathy can be effectively improved; the main treatment indexes, namely uric acid, urine protein, microalbuminuria, transforming growth factor TGF-beta1, blood sugar, low-density lipoprotein and the like are superior to those of an existing clinic first-line medicine captopril; and the important application prospect in treatment of the diabetic nephropathy is displayed.

Description

technical field [0001] The invention belongs to the field of new application of compounds, and relates to two halophenol compounds capable of preventing and treating type II diabetic nephropathy, specifically the compound 4,5,2'-trihydroxy-2,5'-dibromobenzophenone (LM49 ) and compound 4,5,2'-tris(4-morpholineformyloxy)-2,5'-dichlorobenzophenone (A8) in the preparation of anti-Ⅱ diabetic nephropathy drugs. Background technique [0002] Diabetic nephropathy (diabetic nephropathy, DN) is one of the main complications of diabetes, which eventually leads to end-stage renal disease (ESRD). At present, there are 114 million diabetic patients and 140 million prediabetic patients in China. With the continuous increase of diabetic patients worldwide, the prevalence of DN is also increasing. DN is the primary cause of ESRD in western countries, accounting for 25%-42%, and it is also the main cause of ESRD in my country. The prevalence of DN in type II diabetes is about 20%-25%. DN ca...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/12A61K31/5375A61P3/10A61P13/12
CPCA61K31/12A61K31/5375
Inventor 李青山冯秀娥常熔熔韩玲革
Owner SHANXI MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com